David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Consumer Discretionary | 13.7% |
| 3 | Healthcare | 13.3% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Kimberly-Clark
KMB
$36.4B
| $36.2M | 0.05% |
271,751
+101,099
| +59% | +$13M |
|
477
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
| $36.2M | 0.05% |
934,654
+65,750
| +8% | +$2.55M |
|
|
SNBR
478
DELISTED
Sleep Number
SNBR
| $36.2M | 0.05% |
895,949
-329,224
| -27% | -$12.7M |
|
479
Avient
AVNT
$4.1B
| $36.2M | 0.05% |
1,152,501
+438,560
| +61% | +$12.3M |
|
|
CTLT
480
DELISTED
CATALENT, INC.
CTLT
| $36.2M | 0.05% |
667,307
-354,566
| -35% | -$16.2M |
|
|
RDUS
481
DELISTED
Radius Health, Inc.
RDUS
| $36.2M | 0.05% |
1,484,320
+542,670
| +58% | +$11.9M |
|
482
Expeditors International
EXPD
$24.4B
| $36M | 0.04% |
475,096
+230,954
| +95% | +$17.4M |
|
483
Omeros
OMER
$1.39B
| $35.8M | 0.04% |
2,284,543
-300,895
| -12% | -$5.4M |
|
484
Cousins Properties
CUZ
$4.89B
| $35.6M | 0.04% |
983,900
+980,132
| +26,012% | +$36.8M |
|
|
LOGM
485
DELISTED
LogMein, Inc.
LOGM
| $35.6M | 0.04% |
482,987
+304,105
| +170% | +$23.5M |
|
486
Ingredion
INGR
$6.74B
| $35.4M | 0.04% |
428,854
+335,588
| +360% | +$28.9M |
|
487
Kraft Heinz
KHC
$30.3B
| $35.2M | 0.04% |
1,134,142
-1,319,404
| -54% | -$41.6M |
|
488
Evergy
EVRG
$18.7B
| $34.9M | 0.04% |
580,545
+29,604
| +5% | +$1.73M |
|
489
Eastman Chemical
EMN
$8.47B
| $34.9M | 0.04% |
448,138
+75,523
| +20% | +$5.74M |
|
490
RTX Corp
RTX
$283B
| $34.8M | 0.04% |
425,224
-170,975
| -29% | -$14.3M |
|
|
ALXN
491
DELISTED
Alexion Pharmaceuticals
ALXN
| $34.6M | 0.04% |
264,414
+101,955
| +63% | +$13.1M |
|
492
NovoCure
NVCR
$1.99B
| $34.6M | 0.04% |
547,375
-109,506
| -17% | -$5.55M |
|
|
CELG
493
CALL
DELISTED
Celgene Corp
CELG
| $34.6M | 0.04% |
374,300
-533,700
| -59% | -$50.7M |
|
494
Campbell Soup
CPB
$7.14B
| $34.3M | 0.04% |
856,205
-102,053
| -11% | -$4.01M |
|
495
Coca-Cola Europacific Partners
CCEP
$47.7B
| $34.3M | 0.04% |
606,859
-96,302
| -14% | -$5.26M |
|
496
HubSpot
HUBS
$12B
| $34.1M | 0.04% |
199,937
+16,128
| +9% | +$2.82M |
|
497
Canadian Pacific Kansas City
CP
$85B
| $34.1M | 0.04% |
724,145
-422,980
| -37% | -$18.9M |
|
498
Valvoline
VVV
$4.33B
| $33.8M | 0.04% |
1,730,172
+491,102
| +40% | +$9.07M |
|
|
BERY
499
DELISTED
Berry Global Group, Inc.
BERY
| $33.7M | 0.04% |
698,317
-174,653
| -20% | -$8.41M |
|
500
Nasdaq
NDAQ
$54.9B
| $33.7M | 0.04% |
1,050,045
-387,576
| -27% | -$11.9M |
|
Similar funds
David Shaw's Q2 2019 Portfolio in Review
As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
- David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- David Shaw opened 499 new positions and closed 416 in Q2 2019.
- David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.